(Q26825271)

English

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis (English)

1 reference

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

7

object named as

BWJ Mol

1 reference

Patrick Bossuyt

4

object named as

PMM Bossuyt

1 reference

author name string

CE Kleinrouweler

1

1 reference

MMJ Wiegerinck

2

1 reference

C Ris-Stalpers

3

1 reference

JAM van der Post

5

1 reference

P von Dadelszen

6

1 reference

E Pajkrt

8

1 reference

language of work or name

1 reference

publication date

June 2012

1 reference

BJOG: an International Journal of Obstetrics and Gynaecology

1 reference

119

1 reference

7

1 reference

778-87

1 reference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

The two stage model of preeclampsia: variations on the theme

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Placental origins of preeclampsia: challenging the current hypothesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

The diagnostic odds ratio: a single indicator of test performance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Meta-DiSc: a software for meta-analysis of test accuracy data.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Soluble endoglin as a second-trimester marker for preeclampsia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Placental growth factor: a predictive marker for preeclampsia?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

21 January 2018

A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Decreased maternal serum placenta growth factor in early second trimester and preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma placenta growth factor levels in midtrimester pregnancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of macrophage colony stimulating, vascular endothelial, and placenta growth factor in relation to later clinical onset of pre-eclampsia and a small-for-gestational age birth

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2012.03311.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26825271&oldid=1928022446"